DNA vaccines for targeting bacterial infections.

Expert Review of Vaccines
Mariana IngolottiDavid B Weiner

Abstract

DNA vaccination has been of great interest since its discovery in the 1990s due to its ability to elicit both humoral and cellular immune responses. DNA vaccines consist of a DNA plasmid containing a transgene that encodes the sequence of a target protein from a pathogen under the control of a eukaryotic promoter. This revolutionary technology has proven to be effective in animal models and four DNA vaccine products have recently been approved for veterinary use. Although few DNA vaccines against bacterial infections have been tested, the results are encouraging. Because of their versatility, safety and simplicity a wider range of organisms can be targeted by these vaccines, which shows their potential advantages to public health. This article describes the mechanism of action of DNA vaccines and their potential use for targeting bacterial infections. In addition, it provides an updated summary of the methods used to enhance immunogenicity from codon optimization and adjuvants to delivery techniques including electroporation and use of nanoparticles.

References

Mar 23, 1990·Science·J A WolffP L Felgner
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·R N KitsisL A Leinwand
Jul 1, 1995·DNA and Cell Biology·W C LaiS P Pakes
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E F FynanH L Robinson
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·B WangD B Weiner
Nov 27, 1995·Annals of the New York Academy of Sciences·C López-MacíasV Ortiz-Navarrete
Jan 1, 1997·The Journal of Infectious Diseases·C J LukeA G Barbour
Jun 1, 1997·Vaccine·Z Q XiangH C Ertl
Jun 12, 1998·Nature Medicine·C A Bona
Sep 17, 1998·The Journal of Clinical Investigation·J J KimD B Weiner
Jun 24, 1999·Cellular and Molecular Life Sciences : CMLS·D W Kowalczyk, H C Ertl
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·T Kieber-EmmonsD B Weiner
Oct 12, 2000·Biochemical and Biophysical Research Communications·I TodorokiM Itoh
Jan 4, 2001·Medical Microbiology and Immunology·M W HornefI B Autenrieth
Mar 20, 2002·Current Molecular Medicine·A Reyes-Sandoval, H C Ertl
May 7, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhi-Li XuTakao Hayakawa
Jun 18, 2002·Infection and Immunity·S D'SouzaK Huygen
Nov 29, 2002·Current Drug Targets. Infectious Disorders·G B Lesinski, M A Westerink
Mar 27, 2003·Drugs·Monique P Curran, Karen L Goa
Apr 30, 2003·The Journal of Infectious Diseases·Stanley A Plotkin
Jun 5, 2003·International Journal for Parasitology·John DonnellyJeffrey B Ulmer
Dec 13, 2003·Carbohydrate Research·Andrej Weintraub
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Concetta BeninatiGiuseppe Teti
Jul 6, 2004·Immunological Reviews·Anne C Moore, Adrian V S Hill

❮ Previous
Next ❯

Citations

Jun 3, 2011·Human Gene Therapy·Alice RochardPascal Bigey
Sep 16, 2011·Clinical and Vaccine Immunology : CVI·Guocai LiMingchun Ji
Oct 11, 2012·Genetic Vaccines and Therapy·Sarfraz AhmadMark Tangney
Oct 15, 2013·Therapeutic Delivery·Akiko KiriyamaNobuhito Shibata
Sep 17, 2011·Expert Review of Vaccines·Sérgio Costa OliveiraJuliana Cassataro
Mar 13, 2013·Expert Opinion on Biological Therapy·Lorenzo Antonio RamirezJean Boyer
Feb 9, 2016·Zoonoses and Public Health·A D Wales, R H Davies
Jul 10, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Sílvia A FerreiraManuel Vilanova
Jan 30, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Atul SrivastavaMeenakshi Iyer
Oct 2, 2014·Applied Biochemistry and Biotechnology·Mohamamd Mahdi RanjbarMaryam Taheri
Apr 7, 2016·Experimental Biology and Medicine·Eric FarrisAngela K Pannier
Jan 1, 2013·Vaccines·Kouji KobiyamaKen J Ishii
Dec 28, 2018·Biotechnology & Genetic Engineering Reviews·Armando Tejeda-MansirPatricia Guerrero-Germán
Mar 13, 2019·Human Gene Therapy·Nina N SchommerTrevor R F Smith
Feb 2, 2018·Biological & Pharmaceutical Bulletin·Ayumu YanoNaoki Inoue
Mar 25, 2017·Nanomaterials·Fatin M Nawwab Al-DeenMagdalena Plebanski
Aug 11, 2020·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·José Luis Di FabioElizabeth Castañeda
May 13, 2020·Pharmaceutics·Rafael R CastilloMaría Vallet-Regí
Sep 8, 2020·Angewandte Chemie·Christoph O FranckLjiljana Fruk
Dec 23, 2020·Life Sciences·Marcelle Moura SilveiraMarcelo Mendonça
Dec 17, 2020·Cells·Guanbo WangMiguel A Valvano
Nov 13, 2020·Frontiers in Bioengineering and Biotechnology·Lalintip HocharoenPanit Kitsubun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Related Papers

Nature Reviews. Genetics
Michele A Kutzler, David B Weiner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Bernadette FerraroDavid B Weiner
© 2021 Meta ULC. All rights reserved